Novel benzoxaborole, nitroimidazole and aminopyrazoles with activity against experimental cutaneous leishmaniasis

OBJECTIVES: Drugs for Neglected Diseases initiative (DNDi) has identified three chemical lead series, the nitroimidazoles, benzoxaboroles and aminopyrazoles, as innovative treatments for visceral leishmaniasis. The leads discovered using phenotypic screening, were optimised following disease- and co...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Bocxlaer, Katrien, Caridha, Diana, Black, Chad, Vesely, Brian, Leed, Susan, Sciotti, Richard J., Wijnant, Gert-Jan, Yardley, Vanessa, Braillard, Stéphanie, Mowbray, Charles E., Ioset, Jean-Robert, Croft, Simon L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Includes articles from the special issue “Novel therapies for cutaneous leishmaniasis”, pp. 106 - 179
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904836/
https://www.ncbi.nlm.nih.gov/pubmed/30922847
http://dx.doi.org/10.1016/j.ijpddr.2019.02.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904836/
https://www.ncbi.nlm.nih.gov/pubmed/30922847
http://dx.doi.org/10.1016/j.ijpddr.2019.02.002

Ejemplares similares